{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:32:53Z","timestamp":1777084373889,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T00:00:00Z","timestamp":1153180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2007,1,8]]},"DOI":"10.1007\/s00520-006-0101-2","type":"journal-article","created":{"date-parts":[[2006,7,17]],"date-time":"2006-07-17T12:15:38Z","timestamp":1153138538000},"page":"57-62","source":"Crossref","is-referenced-by-count":14,"title":["Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability"],"prefix":"10.1007","volume":"15","author":[{"given":"Emilia","family":"Barcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luz","family":"Azuara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Negro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,7,18]]},"reference":[{"key":"101_CR1","unstructured":"Care pain relief and palliative care (1990) Technical report series 804, WHO, Geneva"},{"key":"101_CR2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/ajhp\/60.12.1268","volume":"60","author":"DS Wagner","year":"2003","unstructured":"Wagner DS, Johnson CE, Cichon-Hensley BK, DeLoach SL (2003) Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle. Am J Health Syst Pharm 60:1268\u20131270","journal-title":"Am J Health Syst Pharm"},{"key":"101_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00520-004-0720-4","volume":"13","author":"W Leppert","year":"2005","unstructured":"Leppert W, Luczak J (2005). The role of tramadol in cancer pain treatment\u2014a review. Support Care Cancer 13: 5\u201317","journal-title":"Support Care Cancer"},{"key":"101_CR4","first-page":"681","volume":"53","author":"U Klotz","year":"2003","unstructured":"Klotz U (2003) Tramadol\u2014the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain. Arzneimittelforschung 53:681\u2013687","journal-title":"Arzneimittelforschung"},{"key":"101_CR5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0885-3924(03)00069-1","volume":"25","author":"F Conno De","year":"2003","unstructured":"De Conno F, Panzeri C, Brunelli C, Saita L, Ripamonti C (2003) Palliative care in a national cancer center: results in 1987 vs. 1993 vs. 2000. J Pain Symptom Manage 25:499\u2013510","journal-title":"J Pain Symptom Manage"},{"key":"101_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1191\/0269216305pm1054oa","volume":"19","author":"P Klepstad","year":"2005","unstructured":"Klepstad P, Kaasa S, Cherny N, Hanks G, de Conno F (2005) Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network. Palliat Med 19:477\u2013484","journal-title":"Palliat Med"},{"key":"101_CR7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0885-3924(99)00060-3","volume":"18","author":"S Grond","year":"1999","unstructured":"Grond S, Radbruch L, Meuser T, Loick G, Sabatowski R, Lehmann K (1999) High-dose tramadol in comparison to low-dose morphine for cancer pain relief. J Pain Symptom Manage 18:174\u2013179","journal-title":"J Pain Symptom Manage"},{"key":"101_CR8","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0885-3924(01)00365-7","volume":"22","author":"CM Herndon","year":"2001","unstructured":"Herndon CM, Fike DS (2001) Continuous subcutaneous infusion practices of United States hospices. J Pain Symptom Manage 22:1027\u20131034","journal-title":"J Pain Symptom Manage"},{"key":"101_CR9","first-page":"161","volume-title":"Pain: clinical manual","author":"M McCaffery","year":"1999","unstructured":"McCaffery M, Pasero C (1999) Pain: clinical manual, 2nd edn. Mosby, St Louis, pp 161\u2013299","edition":"2"},{"key":"101_CR10","first-page":"209","volume":"23","author":"AB Thorsen","year":"1994","unstructured":"Thorsen AB, Yung NS, Leung AC (1994) Administration of drugs by infusion pumps in palliative medicine. Ann Acad Med Singapore 23:209\u2013211","journal-title":"Ann Acad Med Singapore"},{"key":"101_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0885-3924(99)00147-5","volume":"19","author":"C Ripamonti","year":"2000","unstructured":"Ripamonti C, Mercadante S, Groff L, Zecca E, De Conno F, Casuccio A (2000) Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage 19:23\u201334","journal-title":"J Pain Symptom Manage"},{"key":"101_CR12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0885-3924(91)90005-O","volume":"6","author":"F Conno De","year":"1991","unstructured":"De Conno F, Caraceni A, Zecca E, Spoldi E, Ventafrida V (1991) Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage 6:484\u2013486","journal-title":"J Pain Symptom Manage"},{"key":"101_CR13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/ajhp\/62.12.1299","volume":"62","author":"NO Abamy","year":"2005","unstructured":"Abamy NO, Zaghlouol IY, Radwan MA (2005) Compatibility of tramadol hydrochloride injection with selected drugs and solutions. Am J Health Syst Pharm 62:1299\u20131302","journal-title":"Am J Health Syst Pharm"},{"key":"101_CR14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpainsymman.2005.02.011","volume":"30","author":"S Negro","year":"2005","unstructured":"Negro S, Mart\u00edn A, Azuara ML, Sanchez Y, Barcia E (2005) Stability of tramadol and haloperidol for continuous home s.c. infusion. J Pain Symptom Manage 30:192\u2013199","journal-title":"J Pain Symptom Manage"},{"key":"101_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0928-0987(03)00041-1","volume":"19","author":"A Jappinen","year":"2003","unstructured":"Jappinen A, Turpeinen M, Kokki H, Rasi A, Ojanen T, Pelkonen O, Naaranlahti T (2003) Stability of sufentanil and levobupivacaine solutions and a mixture in a 0.9% sodium chloride infusion stored in polypropylene syringes. Eur J Pharm Sci 19:31\u201336","journal-title":"Eur J Pharm Sci"},{"key":"101_CR16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1570-0232(02)00065-X","volume":"772","author":"SH Gan","year":"2002","unstructured":"Gan SH, Ismail R, Wan Adnan WA, Wan Z (2002) Method development and validation of a high-performance liquid chromatographic method for tramadol in human plasma using liquid\u2013liquid extraction. J Chromatogr B Analyt Technol Biomed Life Sci 772:123\u2013129","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"101_CR17","unstructured":"Center for Drug Evaluation and Research (1994) Reviewer guidance: validation of chromatographic methods. US FDA, MD, USA"},{"key":"101_CR18","unstructured":"ICH Q2B (1995) Validation of analytical procedures: methodology. Center for Drug Evaluation and Research, FDA, MD, USA"},{"key":"101_CR19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF03012579","volume":"45","author":"D Hopkins","year":"1998","unstructured":"Hopkins D, Shipton EA, Potgieter D,Van der Merwe CA, Boon J, De Wet C, Murphy J (1998) Comparison of tramadol and morphine via subcutaneous PCA following major orthopaedic surgery. Can J Anaesth 45:435\u2013442","journal-title":"Can J Anaesth"},{"key":"101_CR20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/bja\/57.2.220","volume":"57","author":"G Lewis","year":"1985","unstructured":"Lewis G, Hecker J (1985) Infusion thrombophlebitis. Br J Anaesth 57:220\u2013223","journal-title":"Br J Anaesth"},{"key":"101_CR21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.2042-7158.1996.tb05892.x","volume":"48","author":"J Fransson","year":"1996","unstructured":"Fransson J, Espander-Jansson A (1996) Local tolerance of subcutaneous injections. J Pharm Pharmacol 48:1012\u20131015","journal-title":"J Pharm Pharmacol"},{"key":"101_CR22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/10826079708014142","volume":"20","author":"IY Zaghlouol","year":"1997","unstructured":"Zaghlouol IY, Radwan MA (1997) High performance liquid chromatography determination of tramadol in pharmaceutical dosage forms. J Liq Chromatogr Relat Technol 20:779\u2013787","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"101_CR23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2710.1998.00141.x","volume":"23","author":"GM Peterson","year":"1998","unstructured":"Peterson GM, Miller KA, Galloway JG, Dunnet PF (1998) Compatibility and stability of fentanyl admixtures in polypropylene syringes. J Clin Pharm Ther 23:67\u201372","journal-title":"J Clin Pharm Ther"},{"key":"101_CR24","unstructured":"Database of drug compatibility for syringe drivers (2001) http:\/\/www.pallmed.com . Accessed January 2006"},{"key":"101_CR25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-2710.1998.00165.x","volume":"23","author":"D Schrijvers","year":"1998","unstructured":"Schrijvers D, Tai-Apin C, De Smet MC, Cornil P, Vermorken JB, Bruyneel P (1998) Determination of compatibility and stability of drugs used in palliative care. J Clin Pharm Ther 23:311\u2013314","journal-title":"J Clin Pharm Ther"},{"key":"101_CR26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00520-002-0415-7","volume":"11","author":"E Barcia","year":"2003","unstructured":"Barcia E, Reyes R, Azuara ML, S\u00e1nchez Y, Negro S (2003) Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care. Support Care Cancer 11:107\u2013113","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-006-0101-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-006-0101-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-006-0101-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T21:52:57Z","timestamp":1587073977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-006-0101-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,18]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1,8]]}},"alternative-id":["101"],"URL":"https:\/\/doi.org\/10.1007\/s00520-006-0101-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,18]]}}}